Citation Impact
Citing Papers
Protein characterization of Saccharomyces cerevisiae RNA polymerase II after in vivo cross-linking
2007 StandoutNobel
Identification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia
2017
Global phosphorylation analysis of β-arrestin–mediated signaling downstream of a seven transmembrane receptor (7TMR)
2010 StandoutNobel
Recognition of a Ubiquitous Self Antigen by Prostate Cancer-Infiltrating CD8 + T Lymphocytes
2008 StandoutScienceNobel
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes
2006 StandoutScience
Nuclear Lamin-A Scales with Tissue Stiffness and Enhances Matrix-Directed Differentiation
2013 StandoutScience
Quantum dot/peptide-MHC biosensors reveal strong CD8-dependent cooperation between self and viral antigens that augment the T cell response
2006
High Frequency of Skin-homing Melanocyte-specific Cytotoxic T Lymphocytes in Autoimmune Vitiligo
1998
Combinatorial Cancer Immunotherapy
2006
Activation of Low Avidity CTL Specific for a Self Epitope Results in Tumor Rejection But Not Autoimmunity
1998
T cell defined tumor antigens
1997
Progress in human tumour immunology and immunotherapy
2001 Nature
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Regulation of the Cdk inhibitor p27 and its deregulation in cancer
2000
Immunology and immunotherapy approaches for prostate cancer
2007
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
2001 StandoutNature
Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
2013
Mechanobiology of bone marrow stem cells: From myosin-II forces to compliance of matrix and nucleus in cell forms and fates
2013
A listing of human tumor antigens recognized by T cells
2001
Three Different Binding Sites of Cks1 Are Required for p27-Ubiquitin Ligation
2002 StandoutNobel
Human tumor antigens recognized by T-cells
1997
Cancer vaccines based on the identification of genes encoding cancer regression antigens
1997
Towards patient‐specific tumor antigen selection for vaccination
2002
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
2014
HLA-A2 Restricted, Melanocyte-Specific CD8+ T Lymphocytes Detected in Vitiligo Patients are Related to Disease Activity and are Predominantly Directed Against MelanA/MART1
2001
A listing of human tumor antigens recognized by T cells: March 2004 update
2004
Sources of diversity in T cell epitope discovery
2011
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?
1995
Widespread changes in protein synthesis induced by microRNAs
2008 StandoutNature
Human tumor antigens for cancer vaccine development
1999
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
Quantitative reactivity profiling predicts functional cysteines in proteomes
2010 StandoutNatureNobel
Impact energy measurement in time-of-flight mass spectrometry with cryogenic microcalorimeters
1998 StandoutNatureNobel
Functional Proteomics Reveals the Biochemical Niche of C. elegans DCR-1 in Multiple Small-RNA-Mediated Pathways
2006 StandoutNobel
A New Era for Cancer Immunotherapy Based on the Genes that Encode Cancer Antigens
1999
Comparative assessment of large-scale data sets of protein–protein interactions
2002 StandoutNature
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
2001 StandoutNature
Identification of human tumor antigens and its implications for diagnosis and treatment of cancer
2004
Dendritic cells and the control of immunity
1998 StandoutNatureNobel
Global quantification of mammalian gene expression control
2011 StandoutNature
Proteomics to study genes and genomes
2000 StandoutNature
Multiple Functions of Jab1 Are Required for Early Embryonic Development and Growth Potential in Mice
2004 StandoutNobel
The Turnover Kinetics of Major Histocompatibility Complex Peptides of Human Cancer Cells
2005
Effects of hypoxia and HIFs on cancer metabolism
2012
Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance
1999
In vivoblockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance
1999 StandoutNobel
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
The Immunological Synapse: A Molecular Machine Controlling T Cell Activation
1999 StandoutScience
Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
1996
Detection of self-reactive CD8 + T cells with an anergic phenotype in healthy individuals
2014 StandoutScienceNobel
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
Functional Reconstitution of Class II MHC-Restricted T Cell Immunity Mediated by Retroviral Transfer of the αβ TCR Complex
2000
CD4+CD25−LAG3+regulatory T cells controlled by the transcription factor Egr-2
2009 StandoutNobel
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Rbx1, a Component of the VHL Tumor Suppressor Complex and SCF Ubiquitin Ligase
1999 StandoutScienceNobel
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
The emergence of mass spectrometry in biochemical research.
1994
Lysosomal cathepsin D mediates endogenous mucin glycodomain catabolism in mammals
2022 StandoutNobel
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
A naturally processed peptide presented by HLA-A*0201 is expressed at low abundance and recognized by an alloreactive CD8+ cytotoxic T cell with apparent high affinity.
1997
De novo design of protein homo-oligomers with modular hydrogen-bond network–mediated specificity
2016 StandoutScienceNobel
Mass spectrometry-based proteomics
2003 StandoutNature
Active recycling of yeast Golgi mannosyltransferase complexes through the endoplasmic reticulum
2000 StandoutNobel
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
Does the Immune System See Tumors as Foreign or Self?
2003
Detection of T cell responses to a ubiquitous cellular protein in autoimmune disease
2014 StandoutScienceNobel
Analysis of Proteins and Proteomes by Mass Spectrometry
2001
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
Neoantigens in cancer immunotherapy
2015 StandoutScience
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
2002 StandoutNobel
An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database
1994 Standout
A Fluorogenic Dye Activated by the Staudinger Ligation
2003 StandoutNobel
Enhancement of Antitumor Immunity by CTLA-4 Blockade
1996 StandoutScienceNobel
Compact Biocompatible Quantum Dots Functionalized for Cellular Imaging
2008 StandoutNobel
Mass Spectrometry in Proteomics
2001
PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
2014
Serological analysis of human tumor antigens: molecular definition and implications
1997
Multiple Click-Selective tRNA Synthetases Expand Mammalian Cell-Specific Proteomics
2018 StandoutNobel
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
2002 StandoutNobel
Chemical Glycoproteomics
2016 StandoutNobel
Human tumor antigens recognized by T lymphocytes.
1996
Mass Spectrometry and Protein Analysis
2006 StandoutScience
Works of Ye Chen being referenced
Human extramedullary bone marrow in mice: a novel in vivo model of genetically controlled hematopoietic microenvironment
2012
Expression of G1 cyclins, cyclin-dependent kinases, and cyclin-dependent kinase inhibitors in androgen-induced prostate proliferation in castrated rats.
1996
p53 activation of mesenchymal stromal cells partially abrogates microenvironment-mediated resistance to FLT3 inhibition in AML through HIF-1α–mediated down-regulation of CXCL12
2011
Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell Lines
1994 Science